The Vanguard Group 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:07 am Sale |
2022-12-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
The Vanguard Group | 181,843 2.110% |
-248,235 (-57.72%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
The Vanguard Group | 430,078 5.120% |
430,078 (New Position) |
Filing |